Biosimilars/follow-on-biologics Market Report

Global Biosimilars/follow-on-biologics Market Study Report 2022 Historical Trends, Growth, and Forecast to 2028

  • POSTDATE：Mar 10, 2022
  • PAGES：230
  • REPORT CODE：GMM806585
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • Biosimilars/follow-on-biologics market report explains the definition, types, applications, major countries, and major players of the Biosimilars/follow-on-biologics market. The report mainly contains different types, applications, and regional historical data from 2017-2021 and forecast data from 2022-2028.

    The report contains qualitative and quantitative analysis of the entire industry.

    The influence of COVID-19 has been considered in the report. Coronavirus Impact is included in Chapter 2. In addition, Strategic Analytics to Boost Productivity and Profitability is included in Chapter 3.

    By Player:

    • Teva Pharmaceutical Industries

    • Merck Serono (Merck)

    • Genentech (Roche)

    • Hospira

    • Celltrion Biocon

    • LG Life Sciences

    • Biogen idec

    • Novartis (Sandoz)

    • Synthon Pharmaceuticals

    By Type:

    • Human growth hormone

    • Erythropoietin

    • Monoclonal antibodies

    • Insulin

    • Interferon

    • Granulocyte-Colony Stimulating Factor

    • Others

    By End-User:

    • Blood disorders

    • Oncology diseases

    • Chronic and autoimmune diseases

    • Growth hormone deficiencies

    • Others

    By Region:

    North America

    • United States

    • Canada

    • Mexico

    Europe

    • Germany

    • UK

    • Spain

    • France

    • Italy

    • Denmark

    • Finland

    • Norway

    • Sweden

    • Poland

    • Russia

    • Turkey

    Asia-Pacific

    • China

    • Japan

    • India

    • South Korea

    • Pakistan

    • Bangladesh

    • Indonesia

    • Thailand

    • Singapore

    • Malaysia

    • Philippines

    • Vietnam

    • Others

    South America

    • Brazil

    • Colombia

    • Chile

    • Argentina

    • Venezuela

    • Peru

    • Puerto Rico

    • Ecuador

    • Others

    GCC

    • Bahrain

    • Kuwait

    • Oman

    • Qatar

    • Saudi Arabia

    • United Arab Emirates

    Africa

    • Nigeria

    • South Africa

    • Egypt

    • Algeriat

    • Others

    Oceania

    • Australia

    • New Zealand

  • TABLE OF CONTENT

    1. Global Biosimilars/follow-on-biologics Executive Summary

    • 1.1 Introduction

    • 1.2 Market Panorama, 2022

    2 Coronavirus Impact

    • 2.1 Biosimilars/follow-on-biologics Outlook to 2028- Original Forecasts

    • 2.2 Biosimilars/follow-on-biologics Outlook to 2028- COVID-19 Affected Forecasts

    • 2.3 Impact on Industry

    3 Strategic Analytics to Boost Productivity and Profitability

    • 3.1 Potential Market Drivers and Opportunities

    • 3.2 New Challenges and Strategies

    • 3.3 Short Term and Long Term Biosimilars/follow-on-biologics Market Trends

    4 Key Inferences

    5 Market Overview

    • 5.1 Current Market Scenario

    • 5.2 Porter's Five Forces Analysis

      • 5.2.1 Bargaining Power of Suppliers

      • 5.2.2 Bargaining Power of Consumers

      • 5.2.3 Threat of New Entrants

      • 5.2.4 Threat of Substitute Product and Services

      • 5.2.5 Competitive Rivalry within the Industry

    6 Global Biosimilars/follow-on-biologics Market- Recent Developments

    • 6.1 Biosimilars/follow-on-biologics Market News and Developments

    • 6.2 Biosimilars/follow-on-biologics Market Deals Landscape

    7 Biosimilars/follow-on-biologics Raw Materials and Cost Structure Analysis

    • 7.1 Biosimilars/follow-on-biologics Key Raw Materials

    • 7.2 Biosimilars/follow-on-biologics Price Trend of Key Raw Materials

    • 7.3 Biosimilars/follow-on-biologics Key Suppliers of Raw Materials

    • 7.4 Biosimilars/follow-on-biologics Market Concentration Rate of Raw Materials

    • 7.5 Biosimilars/follow-on-biologics Cost Structure Analysis

      • 7.5.1 Biosimilars/follow-on-biologics Raw Materials Analysis

      • 7.5.2 Biosimilars/follow-on-biologics Labor Cost Analysis

      • 7.5.3 Biosimilars/follow-on-biologics Manufacturing Expenses Analysis

    8 Global Biosimilars/follow-on-biologics Import and Export Analysis (Top 10 Countries)

    • 8.1 Global Biosimilars/follow-on-biologics Import by Region (Top 10 Countries) (2017-2028)

    • 8.2 Global Biosimilars/follow-on-biologics Export by Region (Top 10 Countries) (2017-2028)

    9 Global Biosimilars/follow-on-biologics Market Outlook by Types and Applications to 2022

    • 9.1 Global Biosimilars/follow-on-biologics Consumption and Growth Rate by Type (2017-2022)

      • 9.1.1 Global Human growth hormone Consumption and Growth Rate (2017-2022)

      • 9.1.2 Global Erythropoietin Consumption and Growth Rate (2017-2022)

      • 9.1.3 Global Monoclonal antibodies Consumption and Growth Rate (2017-2022)

      • 9.1.4 Global Insulin Consumption and Growth Rate (2017-2022)

      • 9.1.5 Global Interferon Consumption and Growth Rate (2017-2022)

      • 9.1.6 Global Granulocyte-Colony Stimulating Factor Consumption and Growth Rate (2017-2022)

      • 9.1.7 Global Others Consumption and Growth Rate (2017-2022)

    • 9.2 Global Biosimilars/follow-on-biologics Consumption and Growth Rate by Application (2017-2022)

      • 9.2.1 Global Blood disorders Consumption and Growth Rate (2017-2022)

      • 9.2.2 Global Oncology diseases Consumption and Growth Rate (2017-2022)

      • 9.2.3 Global Chronic and autoimmune diseases Consumption and Growth Rate (2017-2022)

      • 9.2.4 Global Growth hormone deficiencies Consumption and Growth Rate (2017-2022)

      • 9.2.5 Global Others Consumption and Growth Rate (2017-2022)

    10 Region and Country-wise Biosimilars/follow-on-biologics Market Analysis and Outlook till 2022

    • 10.1 Global Biosimilars/follow-on-biologics Consumption (2017-2022)

    • 10.2 North America Consumption Analysis

      • 10.2.1 United States Biosimilars/follow-on-biologics Consumption (2017-2022)

      • 10.2.2 Canada Biosimilars/follow-on-biologics Consumption (2017-2022)

      • 10.2.3 Mexico Biosimilars/follow-on-biologics Consumption (2017-2022)

    • 10.3 Europe Consumption Analysis

      • 10.3.1 Germany Biosimilars/follow-on-biologics Consumption (2017-2022)

      • 10.3.2 UK Biosimilars/follow-on-biologics Consumption (2017-2022)

      • 10.3.3 Spain Biosimilars/follow-on-biologics Consumption (2017-2022)

      • 10.3.4 Belgium Biosimilars/follow-on-biologics Consumption (2017-2022)

      • 10.3.5 France Biosimilars/follow-on-biologics Consumption (2017-2022)

      • 10.3.6 Italy Biosimilars/follow-on-biologics Consumption (2017-2022)

      • 10.3.7 Denmark Biosimilars/follow-on-biologics Consumption (2017-2022)

      • 10.3.8 Finland Biosimilars/follow-on-biologics Consumption (2017-2022)

      • 10.3.9 Norway Biosimilars/follow-on-biologics Consumption (2017-2022)

      • 10.3.10 Sweden Biosimilars/follow-on-biologics Consumption (2017-2022)

      • 10.3.11 Poland Biosimilars/follow-on-biologics Consumption (2017-2022)

      • 10.3.12 Russia Biosimilars/follow-on-biologics Consumption (2017-2022)

      • 10.3.13 Turkey Biosimilars/follow-on-biologics Consumption (2017-2022)

    • 10.4 APAC Consumption Analysis

      • 10.4.1 China Biosimilars/follow-on-biologics Consumption (2017-2022)

      • 10.4.2 Japan Biosimilars/follow-on-biologics Consumption (2017-2022)

      • 10.4.3 India Biosimilars/follow-on-biologics Consumption (2017-2022)

      • 10.4.4 South Korea Biosimilars/follow-on-biologics Consumption (2017-2022)

      • 10.4.5 Pakistan Biosimilars/follow-on-biologics Consumption (2017-2022)

      • 10.4.6 Bangladesh Biosimilars/follow-on-biologics Consumption (2017-2022)

      • 10.4.7 Indonesia Biosimilars/follow-on-biologics Consumption (2017-2022)

      • 10.4.8 Thailand Biosimilars/follow-on-biologics Consumption (2017-2022)

      • 10.4.9 Singapore Biosimilars/follow-on-biologics Consumption (2017-2022)

      • 10.4.10 Malaysia Biosimilars/follow-on-biologics Consumption (2017-2022)

      • 10.4.11 Philippines Biosimilars/follow-on-biologics Consumption (2017-2022)

      • 10.4.12 Vietnam Biosimilars/follow-on-biologics Consumption (2017-2022)

    • 10.5 South America Consumption Analysis

      • 10.5.1 Brazil Biosimilars/follow-on-biologics Consumption (2017-2022)

      • 10.5.2 Colombia Biosimilars/follow-on-biologics Consumption (2017-2022)

      • 10.5.3 Chile Biosimilars/follow-on-biologics Consumption (2017-2022)

      • 10.5.4 Argentina Biosimilars/follow-on-biologics Consumption (2017-2022)

      • 10.5.5 Venezuela Biosimilars/follow-on-biologics Consumption (2017-2022)

      • 10.5.6 Peru Biosimilars/follow-on-biologics Consumption (2017-2022)

      • 10.5.7 Puerto Rico Biosimilars/follow-on-biologics Consumption (2017-2022)

      • 10.5.8 Ecuador Biosimilars/follow-on-biologics Consumption (2017-2022)

    • 10.6 GCC Consumption Analysis

      • 10.6.1 Bahrain Biosimilars/follow-on-biologics Consumption (2017-2022)

      • 10.6.2 Kuwait Biosimilars/follow-on-biologics Consumption (2017-2022)

      • 10.6.3 Oman Biosimilars/follow-on-biologics Consumption (2017-2022)

      • 10.6.4 Qatar Biosimilars/follow-on-biologics Consumption (2017-2022)

      • 10.6.5 Saudi Arabia Biosimilars/follow-on-biologics Consumption (2017-2022)

      • 10.6.6 United Arab Emirates Biosimilars/follow-on-biologics Consumption (2017-2022)

    • 10.7 Africa Consumption Analysis

      • 10.7.1 Nigeria Biosimilars/follow-on-biologics Consumption (2017-2022)

      • 10.7.2 South Africa Biosimilars/follow-on-biologics Consumption (2017-2022)

      • 10.7.3 Egypt Biosimilars/follow-on-biologics Consumption (2017-2022)

      • 10.7.4 Algeria Biosimilars/follow-on-biologics Consumption (2017-2022)

    • 10.8 Oceania Consumption Analysis

      • 10.8.1 Australia Biosimilars/follow-on-biologics Consumption (2017-2022)

      • 10.8.2 New Zealand Biosimilars/follow-on-biologics Consumption (2017-2022)

    11 Global Biosimilars/follow-on-biologics Competitive Analysis

    • 11.1 Teva Pharmaceutical Industries

      • 11.1.1 Teva Pharmaceutical Industries Company Details

      • 11.1.2 Teva Pharmaceutical Industries Biosimilars/follow-on-biologics Sales, Price, Value and Gross Profit (2017-2022)

      • 11.1.3 Teva Pharmaceutical Industries Biosimilars/follow-on-biologics Main Business and Markets Served

      • 11.1.4 Teva Pharmaceutical Industries Biosimilars/follow-on-biologics Product Portfolio

      • 11.1.5 Recent Research and Development Strategies

    • 11.2 Merck Serono (Merck)

      • 11.2.1 Merck Serono (Merck) Company Details

      • 11.2.2 Merck Serono (Merck) Biosimilars/follow-on-biologics Sales, Price, Value and Gross Profit (2017-2022)

      • 11.2.3 Merck Serono (Merck) Biosimilars/follow-on-biologics Main Business and Markets Served

      • 11.2.4 Merck Serono (Merck) Biosimilars/follow-on-biologics Product Portfolio

      • 11.2.5 Recent Research and Development Strategies

    • 11.3 Genentech (Roche)

      • 11.3.1 Genentech (Roche) Company Details

      • 11.3.2 Genentech (Roche) Biosimilars/follow-on-biologics Sales, Price, Value and Gross Profit (2017-2022)

      • 11.3.3 Genentech (Roche) Biosimilars/follow-on-biologics Main Business and Markets Served

      • 11.3.4 Genentech (Roche) Biosimilars/follow-on-biologics Product Portfolio

      • 11.3.5 Recent Research and Development Strategies

    • 11.4 Hospira

      • 11.4.1 Hospira Company Details

      • 11.4.2 Hospira Biosimilars/follow-on-biologics Sales, Price, Value and Gross Profit (2017-2022)

      • 11.4.3 Hospira Biosimilars/follow-on-biologics Main Business and Markets Served

      • 11.4.4 Hospira Biosimilars/follow-on-biologics Product Portfolio

      • 11.4.5 Recent Research and Development Strategies

    • 11.5 Celltrion Biocon

      • 11.5.1 Celltrion Biocon Company Details

      • 11.5.2 Celltrion Biocon Biosimilars/follow-on-biologics Sales, Price, Value and Gross Profit (2017-2022)

      • 11.5.3 Celltrion Biocon Biosimilars/follow-on-biologics Main Business and Markets Served

      • 11.5.4 Celltrion Biocon Biosimilars/follow-on-biologics Product Portfolio

      • 11.5.5 Recent Research and Development Strategies

    • 11.6 LG Life Sciences

      • 11.6.1 LG Life Sciences Company Details

      • 11.6.2 LG Life Sciences Biosimilars/follow-on-biologics Sales, Price, Value and Gross Profit (2017-2022)

      • 11.6.3 LG Life Sciences Biosimilars/follow-on-biologics Main Business and Markets Served

      • 11.6.4 LG Life Sciences Biosimilars/follow-on-biologics Product Portfolio

      • 11.6.5 Recent Research and Development Strategies

    • 11.7 Biogen idec

      • 11.7.1 Biogen idec Company Details

      • 11.7.2 Biogen idec Biosimilars/follow-on-biologics Sales, Price, Value and Gross Profit (2017-2022)

      • 11.7.3 Biogen idec Biosimilars/follow-on-biologics Main Business and Markets Served

      • 11.7.4 Biogen idec Biosimilars/follow-on-biologics Product Portfolio

      • 11.7.5 Recent Research and Development Strategies

    • 11.8 Novartis (Sandoz)

      • 11.8.1 Novartis (Sandoz) Company Details

      • 11.8.2 Novartis (Sandoz) Biosimilars/follow-on-biologics Sales, Price, Value and Gross Profit (2017-2022)

      • 11.8.3 Novartis (Sandoz) Biosimilars/follow-on-biologics Main Business and Markets Served

      • 11.8.4 Novartis (Sandoz) Biosimilars/follow-on-biologics Product Portfolio

      • 11.8.5 Recent Research and Development Strategies

    • 11.9 Synthon Pharmaceuticals

      • 11.9.1 Synthon Pharmaceuticals Company Details

      • 11.9.2 Synthon Pharmaceuticals Biosimilars/follow-on-biologics Sales, Price, Value and Gross Profit (2017-2022)

      • 11.9.3 Synthon Pharmaceuticals Biosimilars/follow-on-biologics Main Business and Markets Served

      • 11.9.4 Synthon Pharmaceuticals Biosimilars/follow-on-biologics Product Portfolio

      • 11.9.5 Recent Research and Development Strategies

    12 Global Biosimilars/follow-on-biologics Market Outlook by Types and Applications to 2028

    • 12.1 Global Biosimilars/follow-on-biologics Consumption Forecast and Growth Rate by Type (2022-2028)

      • 12.1.1 Global Human growth hormone Consumption Forecast and Growth Rate (2022-2028)

      • 12.1.2 Global Erythropoietin Consumption Forecast and Growth Rate (2022-2028)

      • 12.1.3 Global Monoclonal antibodies Consumption Forecast and Growth Rate (2022-2028)

      • 12.1.4 Global Insulin Consumption Forecast and Growth Rate (2022-2028)

      • 12.1.5 Global Interferon Consumption Forecast and Growth Rate (2022-2028)

      • 12.1.6 Global Granulocyte-Colony Stimulating Factor Consumption Forecast and Growth Rate (2022-2028)

      • 12.1.7 Global Others Consumption Forecast and Growth Rate (2022-2028)

    • 12.2 Global Biosimilars/follow-on-biologics Consumption Forecast and Growth Rate by Application (2022-2028)

      • 12.2.1 Global Blood disorders Consumption Forecast and Growth Rate (2022-2028)

      • 12.2.2 Global Oncology diseases Consumption Forecast and Growth Rate (2022-2028)

      • 12.2.3 Global Chronic and autoimmune diseases Consumption Forecast and Growth Rate (2022-2028)

      • 12.2.4 Global Growth hormone deficiencies Consumption Forecast and Growth Rate (2022-2028)

      • 12.2.5 Global Others Consumption Forecast and Growth Rate (2022-2028)

    13 Country-wise Biosimilars/follow-on-biologics Market Analysis and Outlook to 2028

    • 13.1 Global Biosimilars/follow-on-biologics Consumption Forecast (2022-2028)

    • 13.2 North America Consumption Analysis

      • 13.2.1 United States Biosimilars/follow-on-biologics Consumption Forecast (2022-2028)

      • 13.2.2 Canada Biosimilars/follow-on-biologics Consumption Forecast (2022-2028)

      • 13.2.3 Mexico Biosimilars/follow-on-biologics Consumption Forecast (2022-2028)

    • 13.3 Europe Consumption Analysis

      • 13.3.1 Germany Biosimilars/follow-on-biologics Consumption Forecast (2022-2028)

      • 13.3.2 UK Biosimilars/follow-on-biologics Consumption Forecast (2022-2028)

      • 13.3.3 Spain Biosimilars/follow-on-biologics Consumption Forecast (2022-2028)

      • 13.3.4 Belgium Biosimilars/follow-on-biologics Consumption Forecast (2022-2028)

      • 13.3.5 France Biosimilars/follow-on-biologics Consumption Forecast (2022-2028)

      • 13.3.6 Italy Biosimilars/follow-on-biologics Consumption Forecast (2022-2028)

      • 13.3.7 Denmark Biosimilars/follow-on-biologics Consumption Forecast (2022-2028)

      • 13.3.8 Finland Biosimilars/follow-on-biologics Consumption Forecast (2022-2028)

      • 13.3.9 Norway Biosimilars/follow-on-biologics Consumption Forecast (2022-2028)

      • 13.3.10 Sweden Biosimilars/follow-on-biologics Consumption Forecast (2022-2028)

      • 13.3.11 Poland Biosimilars/follow-on-biologics Consumption Forecast (2022-2028)

      • 13.3.12 Russia Biosimilars/follow-on-biologics Consumption Forecast (2022-2028)

      • 13.3.13 Turkey Biosimilars/follow-on-biologics Consumption Forecast (2022-2028)

    • 13.4 APAC Consumption Analysis

      • 13.4.1 China Biosimilars/follow-on-biologics Consumption Forecast (2022-2028)

      • 13.4.2 Japan Biosimilars/follow-on-biologics Consumption Forecast (2022-2028)

      • 13.4.3 India Biosimilars/follow-on-biologics Consumption Forecast (2022-2028)

      • 13.4.4 South Korea Biosimilars/follow-on-biologics Consumption Forecast (2022-2028)

      • 13.4.5 Pakistan Biosimilars/follow-on-biologics Consumption Forecast (2022-2028)

      • 13.4.6 Bangladesh Biosimilars/follow-on-biologics Consumption Forecast (2022-2028)

      • 13.4.7 Indonesia Biosimilars/follow-on-biologics Consumption Forecast (2022-2028)

      • 13.4.8 Thailand Biosimilars/follow-on-biologics Consumption Forecast (2022-2028)

      • 13.4.9 Singapore Biosimilars/follow-on-biologics Consumption Forecast (2022-2028)

      • 13.4.10 Malaysia Biosimilars/follow-on-biologics Consumption Forecast (2022-2028)

      • 13.4.11 Philippines Biosimilars/follow-on-biologics Consumption Forecast (2022-2028)

      • 13.4.12 Vietnam Biosimilars/follow-on-biologics Consumption Forecast (2022-2028)

    • 13.5 South America Consumption Analysis

      • 13.5.1 Brazil Biosimilars/follow-on-biologics Consumption Forecast (2022-2028)

      • 13.5.2 Colombia Biosimilars/follow-on-biologics Consumption Forecast (2022-2028)

      • 13.5.3 Chile Biosimilars/follow-on-biologics Consumption Forecast (2022-2028)

      • 13.5.4 Argentina Biosimilars/follow-on-biologics Consumption Forecast (2022-2028)

      • 13.5.5 Venezuela Biosimilars/follow-on-biologics Consumption Forecast (2022-2028)

      • 13.5.6 Peru Biosimilars/follow-on-biologics Consumption Forecast (2022-2028)

      • 13.5.7 Puerto Rico Biosimilars/follow-on-biologics Consumption Forecast (2022-2028)

      • 13.5.8 Ecuador Biosimilars/follow-on-biologics Consumption Forecast (2022-2028)

    • 13.6 GCC Consumption Analysis

      • 13.6.1 Bahrain Biosimilars/follow-on-biologics Consumption Forecast (2022-2028)

      • 13.6.2 Kuwait Biosimilars/follow-on-biologics Consumption Forecast (2022-2028)

      • 13.6.3 Oman Biosimilars/follow-on-biologics Consumption Forecast (2022-2028)

      • 13.6.4 Qatar Biosimilars/follow-on-biologics Consumption Forecast (2022-2028)

      • 13.6.5 Saudi Arabia Biosimilars/follow-on-biologics Consumption Forecast (2022-2028)

      • 13.6.6 United Arab Emirates Biosimilars/follow-on-biologics Consumption Forecast (2022-2028)

    • 13.7 Africa Consumption Analysis

      • 13.7.1 Nigeria Biosimilars/follow-on-biologics Consumption Forecast (2022-2028)

      • 13.7.2 South Africa Biosimilars/follow-on-biologics Consumption Forecast (2022-2028)

      • 13.7.3 Egypt Biosimilars/follow-on-biologics Consumption Forecast (2022-2028)

      • 13.7.4 Algeria Biosimilars/follow-on-biologics Consumption Forecast (2022-2028)

    • 13.8 Oceania Consumption Analysis

      • 13.8.1 Australia Biosimilars/follow-on-biologics Consumption Forecast (2022-2028)

      • 13.8.2 New Zealand Biosimilars/follow-on-biologics Consumption Forecast (2022-2028)

    14 Conclusions


    The List of Tables and Figures

    • Table Definition of Biosimilars/follow-on-biologics

    • Figure of Biosimilars/follow-on-biologics Picture

    • Table Global Biosimilars/follow-on-biologics Import by Region (Top 10 Countries) (2017-2028)

    • Table Global Biosimilars/follow-on-biologics Export by Region (Top 10 Countries) (2017-2028)

    • Figure Global Human growth hormone Consumption and Growth Rate (2017-2022)

    • Figure Global Erythropoietin Consumption and Growth Rate (2017-2022)

    • Figure Global Monoclonal antibodies Consumption and Growth Rate (2017-2022)

    • Figure Global Insulin Consumption and Growth Rate (2017-2022)

    • Figure Global Interferon Consumption and Growth Rate (2017-2022)

    • Figure Global Granulocyte-Colony Stimulating Factor Consumption and Growth Rate (2017-2022)

    • Figure Global Others Consumption and Growth Rate (2017-2022)

    • Figure Global Blood disorders Consumption and Growth Rate (2017-2022)

    • Figure Global Oncology diseases Consumption and Growth Rate (2017-2022)

    • Figure Global Chronic and autoimmune diseases Consumption and Growth Rate (2017-2022)

    • Figure Global Growth hormone deficiencies Consumption and Growth Rate (2017-2022)

    • Figure Global Others Consumption and Growth Rate (2017-2022)

    • Figure Global Biosimilars/follow-on-biologics Consumption by Country (2017-2022)

    • Table North America Biosimilars/follow-on-biologics Consumption by Country (2017-2022)

    • Figure United States Biosimilars/follow-on-biologics Consumption and Growth Rate (2017-2022)

    • Figure Canada Biosimilars/follow-on-biologics Consumption and Growth Rate (2017-2022)

    • Figure Mexico Biosimilars/follow-on-biologics Consumption and Growth Rate (2017-2022)

    • Table Europe Biosimilars/follow-on-biologics Consumption by Country (2017-2022)

    • Figure Germany Biosimilars/follow-on-biologics Consumption and Growth Rate (2017-2022)

    • Figure UK Biosimilars/follow-on-biologics Consumption and Growth Rate (2017-2022)

    • Figure Spain Biosimilars/follow-on-biologics Consumption and Growth Rate (2017-2022)

    • Figure Belgium Biosimilars/follow-on-biologics Consumption and Growth Rate (2017-2022)

    • Figure France Biosimilars/follow-on-biologics Consumption and Growth Rate (2017-2022)

    • Figure Italy Biosimilars/follow-on-biologics Consumption and Growth Rate (2017-2022)

    • Figure Denmark Biosimilars/follow-on-biologics Consumption and Growth Rate (2017-2022)

    • Figure Finland Biosimilars/follow-on-biologics Consumption and Growth Rate (2017-2022)

    • Figure Norway Biosimilars/follow-on-biologics Consumption and Growth Rate (2017-2022)

    • Figure Sweden Biosimilars/follow-on-biologics Consumption and Growth Rate (2017-2022)

    • Figure Poland Biosimilars/follow-on-biologics Consumption and Growth Rate (2017-2022)

    • Figure Russia Biosimilars/follow-on-biologics Consumption and Growth Rate (2017-2022)

    • Figure Turkey Biosimilars/follow-on-biologics Consumption and Growth Rate (2017-2022)

    • Table APAC Biosimilars/follow-on-biologics Consumption by Country (2017-2022)

    • Figure China Biosimilars/follow-on-biologics Consumption and Growth Rate (2017-2022)

    • Figure Japan Biosimilars/follow-on-biologics Consumption and Growth Rate (2017-2022)

    • Figure India Biosimilars/follow-on-biologics Consumption and Growth Rate (2017-2022)

    • Figure South Korea Biosimilars/follow-on-biologics Consumption and Growth Rate (2017-2022)

    • Figure Pakistan Biosimilars/follow-on-biologics Consumption and Growth Rate (2017-2022)

    • Figure Bangladesh Biosimilars/follow-on-biologics Consumption and Growth Rate (2017-2022)

    • Figure Indonesia Biosimilars/follow-on-biologics Consumption and Growth Rate (2017-2022)

    • Figure Thailand Biosimilars/follow-on-biologics Consumption and Growth Rate (2017-2022)

    • Figure Singapore Biosimilars/follow-on-biologics Consumption and Growth Rate (2017-2022)

    • Figure Malaysia Biosimilars/follow-on-biologics Consumption and Growth Rate (2017-2022)

    • Figure Philippines Biosimilars/follow-on-biologics Consumption and Growth Rate (2017-2022)

    • Figure Vietnam Biosimilars/follow-on-biologics Consumption and Growth Rate (2017-2022)

    • Table South America Biosimilars/follow-on-biologics Consumption by Country (2017-2022)

    • Figure Brazil Biosimilars/follow-on-biologics Consumption and Growth Rate (2017-2022)

    • Figure Colombia Biosimilars/follow-on-biologics Consumption and Growth Rate (2017-2022)

    • Figure Chile Biosimilars/follow-on-biologics Consumption and Growth Rate (2017-2022)

    • Figure Argentina Biosimilars/follow-on-biologics Consumption and Growth Rate (2017-2022)

    • Figure Venezuela Biosimilars/follow-on-biologics Consumption and Growth Rate (2017-2022)

    • Figure Peru Biosimilars/follow-on-biologics Consumption and Growth Rate (2017-2022)

    • Figure Puerto Rico Biosimilars/follow-on-biologics Consumption and Growth Rate (2017-2022)

    • Figure Ecuador Biosimilars/follow-on-biologics Consumption and Growth Rate (2017-2022)

    • Table GCC Biosimilars/follow-on-biologics Consumption by Country (2017-2022)

    • Figure Bahrain Biosimilars/follow-on-biologics Consumption and Growth Rate (2017-2022)

    • Figure Kuwait Biosimilars/follow-on-biologics Consumption and Growth Rate (2017-2022)

    • Figure Oman Biosimilars/follow-on-biologics Consumption and Growth Rate (2017-2022)

    • Figure Qatar Biosimilars/follow-on-biologics Consumption and Growth Rate (2017-2022)

    • Figure Saudi Arabia Biosimilars/follow-on-biologics Consumption and Growth Rate (2017-2022)

    • Figure United Arab Emirates Biosimilars/follow-on-biologics Consumption and Growth Rate (2017-2022)

    • Table Africa Biosimilars/follow-on-biologics Consumption by Country (2017-2022)

    • Figure Nigeria Biosimilars/follow-on-biologics Consumption and Growth Rate (2017-2022)

    • Figure South Africa Biosimilars/follow-on-biologics Consumption and Growth Rate (2017-2022)

    • Figure Egypt Biosimilars/follow-on-biologics Consumption and Growth Rate (2017-2022)

    • Figure Algeria Biosimilars/follow-on-biologics Consumption and Growth Rate (2017-2022)

    • Table Oceania Biosimilars/follow-on-biologics Consumption by Country (2017-2022)

    • Figure Australia Biosimilars/follow-on-biologics Consumption and Growth Rate (2017-2022)

    • Figure New Zealand Biosimilars/follow-on-biologics Consumption and Growth Rate (2017-2022)

    • Table Teva Pharmaceutical Industries Company Details

    • Table Teva Pharmaceutical Industries Biosimilars/follow-on-biologics Sales, Price, Value and Gross Profit (2017-2022)

    • Table Teva Pharmaceutical Industries Biosimilars/follow-on-biologics Main Business and Markets Served

    • Table Teva Pharmaceutical Industries Biosimilars/follow-on-biologics Product Portfolio

    • Table Merck Serono (Merck) Company Details

    • Table Merck Serono (Merck) Biosimilars/follow-on-biologics Sales, Price, Value and Gross Profit (2017-2022)

    • Table Merck Serono (Merck) Biosimilars/follow-on-biologics Main Business and Markets Served

    • Table Merck Serono (Merck) Biosimilars/follow-on-biologics Product Portfolio

    • Table Genentech (Roche) Company Details

    • Table Genentech (Roche) Biosimilars/follow-on-biologics Sales, Price, Value and Gross Profit (2017-2022)

    • Table Genentech (Roche) Biosimilars/follow-on-biologics Main Business and Markets Served

    • Table Genentech (Roche) Biosimilars/follow-on-biologics Product Portfolio

    • Table Hospira Company Details

    • Table Hospira Biosimilars/follow-on-biologics Sales, Price, Value and Gross Profit (2017-2022)

    • Table Hospira Biosimilars/follow-on-biologics Main Business and Markets Served

    • Table Hospira Biosimilars/follow-on-biologics Product Portfolio

    • Table Celltrion Biocon Company Details

    • Table Celltrion Biocon Biosimilars/follow-on-biologics Sales, Price, Value and Gross Profit (2017-2022)

    • Table Celltrion Biocon Biosimilars/follow-on-biologics Main Business and Markets Served

    • Table Celltrion Biocon Biosimilars/follow-on-biologics Product Portfolio

    • Table LG Life Sciences Company Details

    • Table LG Life Sciences Biosimilars/follow-on-biologics Sales, Price, Value and Gross Profit (2017-2022)

    • Table LG Life Sciences Biosimilars/follow-on-biologics Main Business and Markets Served

    • Table LG Life Sciences Biosimilars/follow-on-biologics Product Portfolio

    • Table Biogen idec Company Details

    • Table Biogen idec Biosimilars/follow-on-biologics Sales, Price, Value and Gross Profit (2017-2022)

    • Table Biogen idec Biosimilars/follow-on-biologics Main Business and Markets Served

    • Table Biogen idec Biosimilars/follow-on-biologics Product Portfolio

    • Table Novartis (Sandoz) Company Details

    • Table Novartis (Sandoz) Biosimilars/follow-on-biologics Sales, Price, Value and Gross Profit (2017-2022)

    • Table Novartis (Sandoz) Biosimilars/follow-on-biologics Main Business and Markets Served

    • Table Novartis (Sandoz) Biosimilars/follow-on-biologics Product Portfolio

    • Table Synthon Pharmaceuticals Company Details

    • Table Synthon Pharmaceuticals Biosimilars/follow-on-biologics Sales, Price, Value and Gross Profit (2017-2022)

    • Table Synthon Pharmaceuticals Biosimilars/follow-on-biologics Main Business and Markets Served

    • Table Synthon Pharmaceuticals Biosimilars/follow-on-biologics Product Portfolio

    • Figure Global Human growth hormone Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Erythropoietin Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Monoclonal antibodies Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Insulin Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Interferon Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Granulocyte-Colony Stimulating Factor Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Others Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Blood disorders Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Oncology diseases Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Chronic and autoimmune diseases Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Growth hormone deficiencies Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Others Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Biosimilars/follow-on-biologics Consumption Forecast by Country (2022-2028)

    • Table North America Biosimilars/follow-on-biologics Consumption Forecast by Country (2022-2028)

    • Figure United States Biosimilars/follow-on-biologics Consumption Forecast and Growth Rate (2022-2028)

    • Figure Canada Biosimilars/follow-on-biologics Consumption Forecast and Growth Rate (2022-2028)

    • Figure Mexico Biosimilars/follow-on-biologics Consumption Forecast and Growth Rate (2022-2028)

    • Table Europe Biosimilars/follow-on-biologics Consumption Forecast by Country (2022-2028)

    • Figure Germany Biosimilars/follow-on-biologics Consumption Forecast and Growth Rate (2022-2028)

    • Figure UK Biosimilars/follow-on-biologics Consumption Forecast and Growth Rate (2022-2028)

    • Figure Spain Biosimilars/follow-on-biologics Consumption Forecast and Growth Rate (2022-2028)

    • Figure Belgium Biosimilars/follow-on-biologics Consumption Forecast and Growth Rate (2022-2028)

    • Figure France Biosimilars/follow-on-biologics Consumption Forecast and Growth Rate (2022-2028)

    • Figure Italy Biosimilars/follow-on-biologics Consumption Forecast and Growth Rate (2022-2028)

    • Figure Denmark Biosimilars/follow-on-biologics Consumption Forecast and Growth Rate (2022-2028)

    • Figure Finland Biosimilars/follow-on-biologics Consumption Forecast and Growth Rate (2022-2028)

    • Figure Norway Biosimilars/follow-on-biologics Consumption Forecast and Growth Rate (2022-2028)

    • Figure Sweden Biosimilars/follow-on-biologics Consumption Forecast and Growth Rate (2022-2028)

    • Figure Poland Biosimilars/follow-on-biologics Consumption Forecast and Growth Rate (2022-2028)

    • Figure Russia Biosimilars/follow-on-biologics Consumption Forecast and Growth Rate (2022-2028)

    • Figure Turkey Biosimilars/follow-on-biologics Consumption Forecast and Growth Rate (2022-2028)

    • Table APAC Biosimilars/follow-on-biologics Consumption Forecast by Country (2022-2028)

    • Figure China Biosimilars/follow-on-biologics Consumption Forecast and Growth Rate (2022-2028)

    • Figure Japan Biosimilars/follow-on-biologics Consumption Forecast and Growth Rate (2022-2028)

    • Figure India Biosimilars/follow-on-biologics Consumption Forecast and Growth Rate (2022-2028)

    • Figure South Korea Biosimilars/follow-on-biologics Consumption Forecast and Growth Rate (2022-2028)

    • Figure Pakistan Biosimilars/follow-on-biologics Consumption Forecast and Growth Rate (2022-2028)

    • Figure Bangladesh Biosimilars/follow-on-biologics Consumption Forecast and Growth Rate (2022-2028)

    • Figure Indonesia Biosimilars/follow-on-biologics Consumption Forecast and Growth Rate (2022-2028)

    • Figure Thailand Biosimilars/follow-on-biologics Consumption Forecast and Growth Rate (2022-2028)

    • Figure Singapore Biosimilars/follow-on-biologics Consumption Forecast and Growth Rate (2022-2028)

    • Figure Malaysia Biosimilars/follow-on-biologics Consumption Forecast and Growth Rate (2022-2028)

    • Figure Philippines Biosimilars/follow-on-biologics Consumption Forecast and Growth Rate (2022-2028)

    • Figure Vietnam Biosimilars/follow-on-biologics Consumption Forecast and Growth Rate (2022-2028)

    • Table South America Biosimilars/follow-on-biologics Consumption Forecast by Country (2022-2028)

    • Figure Brazil Biosimilars/follow-on-biologics Consumption Forecast and Growth Rate (2022-2028)

    • Figure Colombia Biosimilars/follow-on-biologics Consumption Forecast and Growth Rate (2022-2028)

    • Figure Chile Biosimilars/follow-on-biologics Consumption Forecast and Growth Rate (2022-2028)

    • Figure Argentina Biosimilars/follow-on-biologics Consumption Forecast and Growth Rate (2022-2028)

    • Figure Venezuela Biosimilars/follow-on-biologics Consumption Forecast and Growth Rate (2022-2028)

    • Figure Peru Biosimilars/follow-on-biologics Consumption Forecast and Growth Rate (2022-2028)

    • Figure Puerto Rico Biosimilars/follow-on-biologics Consumption Forecast and Growth Rate (2022-2028)

    • Figure Ecuador Biosimilars/follow-on-biologics Consumption Forecast and Growth Rate (2022-2028)

    • Table GCC Biosimilars/follow-on-biologics Consumption Forecast by Country (2022-2028)

    • Figure Bahrain Biosimilars/follow-on-biologics Consumption Forecast and Growth Rate (2022-2028)

    • Figure Kuwait Biosimilars/follow-on-biologics Consumption Forecast and Growth Rate (2022-2028)

    • Figure Oman Biosimilars/follow-on-biologics Consumption Forecast and Growth Rate (2022-2028)

    • Figure Qatar Biosimilars/follow-on-biologics Consumption Forecast and Growth Rate (2022-2028)

    • Figure Saudi Arabia Biosimilars/follow-on-biologics Consumption Forecast and Growth Rate (2022-2028)

    • Figure United Arab Emirates Biosimilars/follow-on-biologics Consumption Forecast and Growth Rate (2022-2028)

    • Table Africa Biosimilars/follow-on-biologics Consumption Forecast by Country (2022-2028)

    • Figure Nigeria Biosimilars/follow-on-biologics Consumption Forecast and Growth Rate (2022-2028)

    • Figure South Africa Biosimilars/follow-on-biologics Consumption Forecast and Growth Rate (2022-2028)

    • Figure Egypt Biosimilars/follow-on-biologics Consumption Forecast and Growth Rate (2022-2028)

    • Figure Algeria Biosimilars/follow-on-biologics Consumption Forecast and Growth Rate (2022-2028)

    • Table Oceania Biosimilars/follow-on-biologics Consumption Forecast by Country (2022-2028)

    • Figure Australia Biosimilars/follow-on-biologics Consumption Forecast and Growth Rate (2022-2028)

    • Figure New Zealand Biosimilars/follow-on-biologics Consumption Forecast and Growth Rate (2022-2028)

Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US